Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy

Journal of Leukocyte Biology

Volumn 89, Issue 1, 2011, Pages 31-39

  Mishra, Pravin ^b   Banerjee, Debabrata ^b   Ben Baruch, Adit ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Cancer associated fibroblasts; CXCL12 CXCR4; Mesenchymal stem cells; Tumor associated fibroblasts

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CXCL14 CHEMOKINE; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES; STROMAL CELL DERIVED FACTOR 1;

ANGIOGENESIS; CANCER CELL; CARCINOGENESIS; CELL INTERACTION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; FIBROBLAST; HUMAN; MACROPHAGE; METASTASIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; TUMOR; TUMOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR PROMOTION;

ANIMALS; CELL COMMUNICATION; CHEMOKINES; FIBROBLASTS; HUMANS; NEOPLASMS; PHENOTYPE; TUMOR MICROENVIRONMENT;

EID: 78649637459     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0310182     Document Type: Review

References (99)

1. Balkwill, F., Mantovani, A. (2001) Inflammation and cancer: back to Virchow? Lancet 357, 539-545. (Pubitemid 32173595)
2. Colotta, F., Allavena, P., Sica, A., Garlanda, C., Mantovani, A. (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30, 1073-1081.
3. Coussens, L. M., Werb, Z. (2002) Inflammation and cancer. Nature 420, 860-867.
4. Fidler, I. J. (2002) The organ microenvironment and cancer metastasis. Differentiation 70, 498-505.
5. Fidler, I. J. (2003) The pathogenesis of cancer metastasis: the "seed and soil" hypothesis revisited. Nat. Rev. Cancer 3, 453-458.
6. Mantovani, A., Allavena, P., Sica, A., Balkwill, F. (2008) Cancer-related inflammation. Nature 454, 436-444.
7. Park, C. C., Bissell, M. J., Barcellos-Hoff, M. H. (2000) The influence of the microenvironment on the malignant phenotype. Mol. Med. Today 6, 324-329.
8. Witz, I. P. (2008) Yin-yang activities and vicious cycles in the tumor microenvironment. Cancer Res. 68, 9-13.
9. Ben-Baruch, A. (2006) Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators. Semin. Cancer Biol. 16, 38-52.
10. Rot, A., von Andrian, U. H. (2004) Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 22, 891-928.
11. Bacon, K., Baggiolini, M., Broxmeyer, H., Horuk, R., Lindley, I., Mantovani, A., Maysushima, K., Murphy, P., Nomiyama, H., Oppenheim, J., Rot, A., Schall, T., Tsang, M., Thorpe, R., Van Damme, J., Wadhwa, M., Yoshie, O., Zlotnik, A., Zoon, K. (2002) Chemokine/chemokine receptor nomenclature. J. Interferon Cytokine Res. 22, 1067-1068.
12. Sallusto, F., Mackay, C. R., Lanzavecchia, A. (2000) The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 18, 593-620. (Pubitemid 30365392)
13. Zlotnik, A., Yoshie, O. (2000) Chemokines: a new classification system and their role in immunity. Immunity 12, 121-127. (Pubitemid 30398626)
14. Mantovani, A., Bonecchi, R., Locati, M. (2006) Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat. Rev. Immunol. 6, 907-918. (Pubitemid 44851733)
15. Balkwill, F. (2004) Cancer and the chemokine network. Nat. Rev. Cancer 4, 540-550.
16. Ben-Baruch, A. (2006) The multifaceted roles of chemokines in malignancy. Cancer Metastasis Rev. 25, 357-371.
17. Lazennec, G., Richmond, A. (2010) Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol. Med. 16, 133-144.
18. Keeley, E. C., Mehrad, B., Strieter, R. M. (2008) Chemokines as mediators of neovascularization. Arterioscler. Thromb. Vasc. Biol. 28, 1928-1936.
19. Zlotnik, A. (2006) Chemokines and cancer. Int. J. Cancer 119, 2026-2029.
20. Ben-Baruch, A. (2009) Site-specific metastasis formation: chemokines as regulators of tumor cell adhesion, motility and invasion. Cell Adh. Migr. 3, 328-333.
21. Soria, G., Ben-Baruch, A. (2008) The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Lett. 267, 271-285.
22. Conti, I., Rollins, B. J. (2004) CCL2 (monocyte chemoattractant protein- 1) and cancer. Semin. Cancer Biol. 14, 149-154. (Pubitemid 38586739)
23. Allavena, P., Sica, A., Solinas, G., Porta, C., Mantovani, A. (2008) The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit. Rev. Oncol. Hematol. 66, 1-9.
24. Lewis, C. E., Hughes, R. (2007) Inflammation and breast cancer. Microenvironmental factors regulating macrophage function in breast tumors: hypoxia and angiopoietin-2. Breast Cancer Res. 9, 209.
25. Mantovani, A., Sica, A., Allavena, P., Garlanda, C., Locati, M. (2009) Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation. Hum. Immunol. 70, 325-330.
26. Sica, A., Allavena, P., Mantovani, A. (2008) Cancer related inflammation: the macrophage connection. Cancer Lett. 267, 204-215.
27. Mehrad, B., Keane, M. P., Strieter, R. M. (2007) Chemokines as mediators of angiogenesis. Thromb. Haemost. 97, 755-762.
28. Salcedo, R., Oppenheim, J. J. (2003) Role of chemokines in angiogenesis: CXCL12/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses. Microcirculation 10, 359-370.
29. Waugh, D. J., Wilson, C. (2008) The interleukin-8 pathway in cancer. Clin. Cancer Res. 14, 6735-6741.
30. Ratajczak, M. Z., Zuba-Surma, E., Kucia, M., Reca, R., Wojakowski, W., Ratajczak, J. (2006) The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia 20, 1915-1924.
31. Ben-Baruch, A. (2008) Organ selectivity in metastasis: regulation by chemokines and their receptors. Clin. Exp. Metastasis 25, 345-356.
32. Zlotnik, A. (2006) Involvement of chemokine receptors in organ-specific metastasis. Contrib. Microbiol. 13, 191-199.
33. Wang, J., Loberg, R., Taichman, R. S. (2006) The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis. Cancer Metastasis Rev. 25, 573-587. (Pubitemid 46071864)
34. Murakami, T., Cardones, A. R., Hwang, S. T. (2004) Chemokine receptors and melanoma metastasis. J. Dermatol. Sci. 36, 71-78.
35. Payne, A. S., Cornelius, L. A. (2002) The role of chemokines in melanoma tumor growth and metastasis. J. Invest. Dermatol. 118, 915-922. (Pubitemid 34639168)
36. Wu, X., Lee, V. C., Chevalier, E., Hwang, S. T. (2009) Chemokine receptors as targets for cancer therapy. Curr. Pharm. Des. 15, 742-757.
37. Sorrell, J. M., Caplan, A. I. (2009) Fibroblasts - a diverse population at the center of it all. Int. Rev. Cell Mol. Biol. 276, 161-214.
38. Orimo, A., Weinberg, R. A. (2006) Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 5, 1597-1601. (Pubitemid 44285243)
39. Kunz-Schughart, L. A., Knuechel, R. (2002) Tumor-associated fibroblasts (part II): functional impact on tumor tissue. Histol. Histopathol. 17, 623-637.
40. Kalluri, R., Zeisberg, M. (2006) Fibroblasts in cancer. Nat. Rev. Cancer 6, 392-401.
41. Mishra, P. J., Glod, J. W., Banerjee, D. (2009) Mesenchymal stem cells: flip side of the coin. Cancer Res. 69, 1255-1258.
42. Littlepage, L. E., Egeblad, M., Werb, Z. (2005) Coevolution of cancer and stromal cellular responses. Cancer Cell 7, 499-500. (Pubitemid 40799241)
43. Egeblad, M., Littlepage, L. E., Werb, Z. (2005) The fibroblastic coconspirator in cancer progression. Cold Spring Harb. Symp. Quant. Biol. 70, 383-388.
44. Ostman, A., Augsten, M. (2009) Cancer-associated fibroblasts and tumor growth - bystanders turning into key players. Curr. Opin. Genet. Dev. 19, 67-73.
45. Mishra, P. J., Humeniuk, R., Medina, D. J., Alexe, G., Mesirov, J. P., Ganesan, S., Glod, J. W., Banerjee, D. (2008) Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res. 68, 4331-4339.
46. Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., Weinberg, R. A. (2007) Mesenchymal stem cells within tumor stroma promote breast cancer metastasis. Nature 449, 557-563.
47. Spaeth, E. L., Dembinski, J. L., Sasser, A. K., Watson, K., Klopp, A., Hall, B., Andreeff, M., Marini, F. (2009) Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One 4, e4992.
48. Ishii, G., Sangai, T., Oda, T., Aoyagi, Y., Hasebe, T., Kanomata, N., Endoh, Y., Okumura, C., Okuhara, Y., Magae, J., Emura, M., Ochiya, T., Ochiai, A. (2003) Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction. Biochem. Biophys. Res. Commun. 309, 232-240.
49. Guo, X., Oshima, H., Kitmura, T., Taketo, M. M., Oshima, M. (2008) Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer. J. Biol. Chem. 283, 19864-19871.
50. Paland, N., Kamer, I., Kogan-Sakin, I., Madar, S., Goldfinger, N., Rotter, V. (2009) Differential influence of normal and cancer-associated fibroblasts on the growth of human epithelial cells in an in vitro cocultivation model of prostate cancer. Mol. Cancer Res. 7, 1212-1223.
51. Shimoda, M., Mellody, K. T., Orimo, A. (2010) Carcinoma-associated fibroblasts are a rate-limiting determinant for tumor progression. Semin. Cell Dev. Biol. 21, 19-25.
52. Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., Weinberg, R. A. (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335-348.
53. Silzle, T., Randolph, G. J., Kreutz, M., Kunz-Schughart, L. A. (2004) The fibroblast: sentinel cell and local immune modulator in tumor tissue. Int. J. Cancer 108, 173-180.
54. Ao, M., Franco, O. E., Park, D., Raman, D., Williams, K., Hayward, S. W. (2007) Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Cancer Res. 67, 4244-4253.
55. Wang, J., Ying, G., Jung, Y., Lu, J., Zhu, J., Pienta, K. J., Taichman, R. S. (2010) Characterization of phosphoglycerate kinase-1 expression of stromal cells derived from tumor microenvironment in prostate cancer progression. Cancer Res. 70, 471-480.
56. Kalluri, R., Weinberg, R. A. (2009) The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119, 1420-1428.
57. Kunz-Schughart, L. A., Knuechel, R. (2002) Tumor-associated fibroblasts (part I): active stromal participants in tumor development and progression? Histol. Histopathol. 17, 599-621.
58. Mueller, L., Goumas, F. A., Affeldt, M., Sandtner, S., Gehling, U. M., Brilloff, S., Walter, J., Karnatz, N., Lamszus, K., Rogiers, X., Broering, D. C. (2007) Stromal fibroblasts in colorectal liver metastases originate from resident fibroblasts and generate an inflammatory microenvironment. Am. J. Pathol. 171, 1608-1618.
59. Radisky, D. C., Kenny, P. A., Bissell, M. J. (2007) Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT? J. Cell. Biochem. 101, 830-839.
60. Direkze, N. C., Hodivala-Dilke, K., Jeffery, R., Hunt, T., Poulsom, R., Oukrif, D., Alison, M. R., Wright, N. A. (2004) Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res. 64, 8492-8495. (Pubitemid 39552057)
61. Okamoto, R., Yajima, T., Yamazaki, M., Kanai, T., Mukai, M., Okamoto, S., Ikeda, Y., Hibi, T., Inazawa, J., Watanabe, M. (2002) Damaged epithelia regenerated by bone marrow-derived cells in the human gastrointestinal tract. Nat. Med. 8, 1011-1017.
62. Marrache, F., Pendyala, S., Bhagat, G., Betz, K. S., Song, Z., Wang, T. C. (2008) Role of bone marrow-derived cells in experimental chronic pancreatitis. Gut 57, 1113-1120.
63. Gonda, T. A., Varro, A., Wang, T. C., Tycko, B. (2010) Molecular biology of cancer-associated fibroblasts: can these cells be targeted in anti-cancer therapy? Semin. Cell Dev. Biol. 21, 2-10.
64. Kidd, S., Spaeth, E., Dembinski, J. L., Dietrich, M., Watson, K., Klopp, A., Battula, V. L., Weil, M., Andreeff, M., Marini, F. C. (2009) Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells 27, 2614-2623.
65. Bhakta, S., Hong, P., Koc, O. (2006) The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation. Cardiovasc. Revasc. Med. 7, 19-24.
66. Croitoru-Lamoury, J., Lamoury, F. M., Zaunders, J. J., Veas, L. A., Brew, B. J. (2007) Human mesenchymal stem cells constitutively express chemokines and chemokine receptors that can be upregulated by cytokines, IFN-β, and copaxone. J. Interferon Cytokine Res. 27, 53-64. (Pubitemid 46185062)
67. Eck, S. M., Cote, A. L., Winkelman, W. D., Brinckerhoff, C. E. (2009) CXCR4 and matrix metalloproteinase-1 are elevated in breast carcinoma-associated fibroblasts and in normal mammary fibroblasts exposed to factors secreted by breast cancer cells. Mol. Cancer Res. 7, 1033-1044.
68. Gao, H., Priebe, W., Glod, J., Banerjee, D. (2009) Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium. Stem Cells 27, 857-865.
69. Son, B. R., Marquez-Curtis, L. A., Kucia, M., Wysoczynski, M., Turner, A. R., Ratajczak, J., Ratajczak, M. Z., Janowska-Wieczorek, A. (2006) Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells 24, 1254-1264.
70. Wynn, R. F., Hart, C. A., Corradi-Perini, C., O'Neill, L., Evans, C. A., Wraith, J. E., Fairbairn, L. J., Bellantuono, I. (2004) A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 104, 2643-2645. (Pubitemid 39434942)
71. Zhang, F., Tsai, S., Kato, K., Yamanouchi, D., Wang, C., Rafii, S., Liu, B., Kent, K. C. (2009) Transforming growth factor-β promotes recruitment of bone marrow cells and bone marrow-derived mesenchymal stem cells through stimulation of MCP-1 production in vascular smooth muscle cells. J. Biol. Chem. 284, 17564-17574.
72. Menon, L. G., Picinich, S., Koneru, R., Gao, H., Lin, S. Y., Koneru, M., Mayer-Kuckuk, P., Glod, J., Banerjee, D. (2007) Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells. Stem Cells 25, 520-528.
73. Jodele, S., Blavier, L., Yoon, J. M., DeClerck, Y. A. (2006) Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression. Cancer Metastasis Rev. 25, 35-43.
74. Enzerink, A., Salmenpera, P., Kankuri, E., Vaheri, A. (2009) Clustering of fibroblasts induces proinflammatory chemokine secretion promoting leukocyte migration. Mol. Immunol. 46, 1787-1795.
75. Sotgia, F., Del Galdo, F., Casimiro, M. C., Bonuccelli, G., Mercier, I., Whitaker-Menezes, D., Daumer, K. M., Zhou, J., Wang, C., Katiyar, S., Xu, H., Bosco, E., Quong, A. A., Aronow, B., Witkiewicz, A. K., Minetti, C., Frank, P. G., Jimenez, S. A., Knudsen, E. S., Pestell, R. G., Lisanti, M. P. (2009) Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts. Am. J. Pathol. 174, 746-761.
76. Joesting, M. S., Perrin, S., Elenbaas, B., Fawell, S. E., Rubin, J. S., Franco, O. E., Hayward, S. W., Cunha, G. R., Marker, P. C. (2005) Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer. Cancer Res. 65, 10423-10430. (Pubitemid 41743736)
77. Erez, N., Truitt, M., Olson, P., Hanahan, D. (2010) Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-κB-dependent manner. Cancer Cell 17, 135-147.
78. Yang, S., Pham, L. K., Liao, C. P., Frenkel, B., Reddi, A. H., Roy-Burman, P. (2008) A novel bone morphogenetic protein signaling in heterotypic cell interactions in prostate cancer. Cancer Res. 68, 198-205. (Pubitemid 351380121)
79. Ohira, S., Sasaki, M., Harada, K., Sato, Y., Zen, Y., Isse, K., Kozaka, K., Ishikawa, A., Oda, K., Nimura, Y., Nakanuma, Y. (2006) Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-α and stromal-derived factor-1 released in stroma. Am. J. Pathol. 168, 1155-1168.
80. Ohira, S., Itatsu, K., Sasaki, M., Harada, K., Sato, Y., Zen, Y., Ishikawa, A., Oda, K., Nagasaka, T., Nimura, Y., Nakanuma, Y. (2006) Local balance of transforming growth factor-β1 secreted from cholangiocarcinoma cells and stromal-derived factor-1 secreted from stromal fibroblasts is a factor involved in invasion of cholangiocarcinoma. Pathol. Int. 56, 381-389.
81. Chang, S. C., Lin, P. C., Yang, S. H., Wang, H. S., Li, A. F., Lin, J. K. (2009) SDF-1α G801A polymorphism predicts lymph node metastasis in stage T3 colorectal cancer. Ann. Surg. Oncol. 16, 2323-2330.
82. Daly, A. J., McIlreavey, L., Irwin, C. R. (2008) Regulation of HGF and SDF-1 expression by oral fibroblasts - implications for invasion of oral cancer. Oral Oncol. 44, 646-651.
83. Matsuo, Y., Ochi, N., Sawai, H., Yasuda, A., Takahashi, H., Funahashi, H., Takeyama, H., Tong, Z., Guha, S. (2009) CXCL8/IL-8 and CXCL12/SDF-1α co-operatively promote invasiveness and angiogenesis in pancreatic cancer. Int. J. Cancer 124, 853-861.
84. Begley, L., Monteleon, C., Shah, R. B., Macdonald, J. W., Macoska, J. A. (2005) CXCL12 overexpression and secretion by aging fibroblasts enhance human prostate epithelial proliferation in vitro. Aging Cell 4, 291-298. (Pubitemid 43918278)
85. Moskovits, N., Kalinkovich, A., Bar, J., Lapidot, T., Oren, M. (2006) p53 Attenuates cancer cell migration and invasion through repression of SDF-1/CXCL12 expression in stromal fibroblasts. Cancer Res. 66, 10671-10676. (Pubitemid 44876961)
86. Zhao, H., Peehl, D. M. (2009) Tumor-promoting phenotype of CD90hi prostate cancer-associated fibroblasts. Prostate 69, 991-1000.
87. Aldinucci, D., Lorenzon, D., Cattaruzza, L., Pinto, A., Gloghini, A., Carbone, A., Colombatti, A. (2008) Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions. Int. J. Cancer 122, 769-776.
88. Silzle, T., Kreutz, M., Dobler, M. A., Brockhoff, G., Knuechel, R., Kunz-Schughart, L. A. (2003) Tumor-associated fibroblasts recruit blood monocytes into tumor tissue. Eur. J. Immunol. 33, 1311-1320. (Pubitemid 36612030)
89. Dagouassat, M., Suffee, N., Hlawaty, H., Haddad, O., Charni, F., Laguillier, C., Vassy, R., Martin, L., Schischmanoff, P. O., Gattegno, L., Oudar, O., Sutton, A., Charnaux, N. (2010) Monocyte chemoattractant protein-1 (MCP-1)/CCL2 secreted by hepatic myofibroblasts promotes migration and invasion of human hepatoma cells. Int. J. Cancer 126, 1095-1108.
90. Jung, D.W., Che, Z.M., Kim, J., Kim, K., Kim, K.Y., Williams, D. (2009) Tumor-stromal crosstalk in invasion of oral squamous cell carcinoma: a pivotal role of CCL7. Int. J. Cancer 127, 332-344.
91. Augsten, M., Hagglof, C., Olsson, E., Stolz, C., Tsagozis, P., Levchenko, T., Frederick, M. J., Borg, A., Micke, P., Egevad, L., Ostman, A. (2009) CXCL14 is an autocrine growth factor for fibroblasts and acts as a multimodal stimulator of prostate tumor growth. Proc. Natl. Acad. Sci. USA 106, 3414-3419.
92. Ryningen, A., Wergeland, L., Glenjen, N., Gjertsen, B. T., Bruserud, O. (2005) In vitro crosstalk between fibroblasts and native human acute myelogenous leukemia (AML) blasts via local cytokine networks results in increased proliferation and decreased apoptosis of AML cells as well as increased levels of proangiogenic interleukin 8. Leuk. Res. 29, 185-196.
93. Li, L., Dragulev, B., Zigrino, P., Mauch, C., Fox, J. W. (2009) The invasive potential of human melanoma cell lines correlates with their ability to alter fibroblast gene expression in vitro and the stromal microenvironment in vivo. Int. J. Cancer 125, 1796-1804.
94. Jeon, E. S., Heo, S. C., Lee, I. H., Choi, Y. J., Park, J. H., Choi, K. U., Park, D. Y., Suh, D. S., Yoon, M. S., Kim, J. H. (2010) Ovarian cancer-derived lysophosphatidic acid stimulates secretion of VEGF and stromal cell-derived factor-1 α from human mesenchymal stem cells. Exp. Mol. Med. 42, 280-293.
95. Gallagher, P. G., Bao, Y., Prorock, A., Zigrino, P., Nischt, R., Politi, V., Mauch, C., Dragulev, B., Fox, J. W. (2005) Gene expression profiling reveals cross-talk between melanoma and fibroblasts: implications for hosttumor interactions in metastasis. Cancer Res. 65, 4134-4146.
96. Picinich, S. C., Mishra, P. J., Glod, J., Banerjee, D. (2007) The therapeutic potential of mesenchymal stem cells. Cell- & tissue-based therapy. Expert Opin. Biol. Ther. 7, 965-973.
97. Psaltis, P. J., Zannettino, A. C., Worthley, S. G., Gronthos, S. (2008) Concise review: mesenchymal stromal cells: potential for cardiovascular repair. Stem Cells 26, 2201-2210.
98. Uccelli, A., Moretta, L., Pistoia, V. (2008) Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 8, 726-736.
99. Hall, B., Dembinski, J., Sasser, A. K., Studeny, M., Andreeff, M., Marini, F. (2007) Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles. Int. J. Hematol. 86, 8-16.